111 related articles for article (PubMed ID: 19811848)
1. Treatment of psoriasis in patients with hepatitis C: from the Medical Board of the National Psoriasis Foundation.
Frankel AJ; Van Voorhees AS; Hsu S; Korman NJ; Lebwohl MG; Bebo BF; Gottlieb AB;
J Am Acad Dermatol; 2009 Dec; 61(6):1044-55. PubMed ID: 19811848
[TBL] [Abstract][Full Text] [Related]
2. Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation.
Menon K; Van Voorhees AS; Bebo BF; Gladman DD; Hsu S; Kalb RE; Lebwohl MG; Strober BE;
J Am Acad Dermatol; 2010 Feb; 62(2):291-9. PubMed ID: 19646777
[TBL] [Abstract][Full Text] [Related]
3. Review of treatment options for psoriasis in pregnant or lactating women: from the Medical Board of the National Psoriasis Foundation.
Bae YS; Van Voorhees AS; Hsu S; Korman NJ; Lebwohl MG; Young M; Bebo B; Kimball AB;
J Am Acad Dermatol; 2012 Sep; 67(3):459-77. PubMed ID: 22018758
[TBL] [Abstract][Full Text] [Related]
4. Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation.
Rosenbach M; Hsu S; Korman NJ; Lebwohl MG; Young M; Bebo BF; Van Voorhees AS;
J Am Acad Dermatol; 2010 Apr; 62(4):655-62. PubMed ID: 19665821
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference.
Rosmarin DM; Lebwohl M; Elewski BE; Gottlieb AB;
J Am Acad Dermatol; 2010 May; 62(5):838-53. PubMed ID: 19932926
[TBL] [Abstract][Full Text] [Related]
6. Advances in the treatment of hepatitis C.
Lawrence SP
Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
[TBL] [Abstract][Full Text] [Related]
7. Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of 3 cases.
Magliocco MA; Gottlieb AB
J Am Acad Dermatol; 2004 Oct; 51(4):580-4. PubMed ID: 15389194
[TBL] [Abstract][Full Text] [Related]
8. Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation.
Kalb RE; Bagel J; Korman NJ; Lebwohl MG; Young M; Horn EJ; Van Voorhees AS;
J Am Acad Dermatol; 2009 Jan; 60(1):120-4. PubMed ID: 19103363
[TBL] [Abstract][Full Text] [Related]
9. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan.
Feldman SR; Evans C; Russell MW
J Dermatolog Treat; 2005 Feb; 16(1):37-42. PubMed ID: 15897166
[TBL] [Abstract][Full Text] [Related]
10. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
[TBL] [Abstract][Full Text] [Related]
11. Treatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis Foundation.
Chan CS; Van Voorhees AS; Lebwohl MG; Korman NJ; Young M; Bebo BF; Kalb RE; Hsu S
J Am Acad Dermatol; 2009 Jun; 60(6):962-71. PubMed ID: 19375191
[TBL] [Abstract][Full Text] [Related]
12. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.
Antúnez I; Aponte N; Fernández-Carbia A; Rodríguez-Perez F; Toro DH
P R Health Sci J; 2004 Jun; 23(2 Suppl):57-60. PubMed ID: 16929588
[TBL] [Abstract][Full Text] [Related]
13. Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation.
Robinson A; Van Voorhees AS; Hsu S; Korman NJ; Lebwohl MG; Bebo BF; Kalb RE
J Am Acad Dermatol; 2012 Aug; 67(2):279-88. PubMed ID: 22609220
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of viral activity in dual infection with hepatitis B and C in chronic liver disease.
Guptan RC; Thakur V; Malhotra V; Sarin SK
J Assoc Physicians India; 2002 May; 50(5):651-5. PubMed ID: 12186118
[TBL] [Abstract][Full Text] [Related]
15. Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data.
Paradisi A; Caldarola G; Capizzi R; Siciliano M; Annichiarico E; Vecchio FM; Amerio PL; De Simone C
J Am Acad Dermatol; 2010 Jun; 62(6):1067-9. PubMed ID: 20466184
[No Abstract] [Full Text] [Related]
16. Initial experience with routine administration of etanercept in psoriasis.
de Groot M; Appelman M; Spuls PI; de Rie MA; Bos JD
Br J Dermatol; 2006 Oct; 155(4):808-14. PubMed ID: 16965432
[TBL] [Abstract][Full Text] [Related]
17. Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4.
Soriano V; Núñez M; Sánchez-Conde M; Barreiro P; García-Samaniego J; Martín-Carbonero L; Romero M; González-Lahoz J
Antivir Ther; 2005; 10(1):167-70. PubMed ID: 15751774
[TBL] [Abstract][Full Text] [Related]
18. Etanercept therapy for psoriasis in a patient with concomitant hepatitis C and liver transplant.
Collazo MH; González JR; Torres EA
P R Health Sci J; 2008 Dec; 27(4):346-7. PubMed ID: 19069362
[TBL] [Abstract][Full Text] [Related]
19. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
Chehadeh W; Al-Nakib W
J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW;
Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
